ENEURA THERAPEUTICS
ENeura Therapeutics is a medical technology company developing transcranial magnetic stimulation devices for the treatment of migraines. It pioneers the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for the treatment of migraine. Prescribed by physicians but designed for patient use, it is the first truly portable, convenient TMS product that will allow migraine patients to administer treatment as needed—at home, in the office, or on the go.
ENEURA THERAPEUTICS
Industry:
Biotechnology Health Care Medical Medical Device Therapeutics
Founded:
2000-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.eneura.com
Total Employee:
11+
Status:
Active
Contact:
(667) 401-5580
Email Addresses:
[email protected]
Total Funding:
75.79 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Functional Neuromodulation
Functional Neuromodulation is a medical technology company developing neuromodulation technologies for cognitive and memory disorders.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Abell Foundation
Abell Foundation investment in Series D - eNeura Therapeutics
David Oros
David Oros investment in Series D - eNeura Therapeutics
Marc Blum
Marc Blum investment in Series D - eNeura Therapeutics
Camden Partners
Camden Partners investment in Series D - eNeura Therapeutics
MedVenture Associates
MedVenture Associates investment in Venture Round - eNeura Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Series B - eNeura Therapeutics
InterWest Partners
InterWest Partners investment in Series B - eNeura Therapeutics
Domain Associates
Domain Associates investment in Series B - eNeura Therapeutics
MedVenture Associates
MedVenture Associates investment in Series B - eNeura Therapeutics
Technology Partners
Technology Partners investment in Series B - eNeura Therapeutics
Official Site Inspections
http://www.eneura.com Semrush global rank: 5.56 M Semrush visits lastest month: 1.52 K
- Host name: 153.157.174.34.bc.googleusercontent.com
- IP address: 34.174.157.153
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "eNeura Therapeutics"
eNeura Therapeutics - Crunchbase Company Profile & Funding
ENeura Therapeutics is a medical technology company developing transcranial magnetic stimulation devices for the treatment of migraines. It pioneers the use of portable, non-invasive …See details»
eNeura - LinkedIn
ENeura Health and Human Services SAVI Dual is the only clinically effective central neuromodulation therapy developed to treat acute and future attacks.See details»
Eneura
Prior to joining eNeura, Dr. Rosen was the President and COO of Aratana Therapeutics, a pharmaceutical company that he founded while Entrepreneur in Residence at MPM Capital. Prior to joining MPM Capital, he was the head of …See details»
eNeura Company Profile 2024: Valuation, Funding & Investors
ENeura General Information Description. Developer of transcranial magnetic stimulation devices designed to treat migraines. The company's device helps pre-empt migraines to reduce the …See details»
eNeura Company Profile - Office Locations, Competitors, Revenue …
ENeura Inc., a privately held medical technology company, is pioneering the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. …See details»
eNeura - Overview, News & Similar companies | ZoomInfo.com
Who is eNeura. eNeura, Inc. is a privately held medical technology company that is pioneering the use of portable, non-invasive, non-drug treatment and prevention of migraine. sTMS is a …See details»
Eneura
Welcome to the heart of innovation and expertise in medical advancement – the eNeura Medical Advisory Board. At eNeura, we are dedicated to pioneering transformative solutions in healthcare, particularly in the field of neurology.Our …See details»
eNeura Therapeutics - VentureRadar
ENeura Inc., a privately held medical technology company, is pioneering the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. …See details»
eNeura Therapeutics - Funding, Financials, Valuation & Investors
Their latest funding was raised on Nov 4, 2019 from a Debt Financing round. eNeura Therapeutics is funded by 10 investors. Abell Foundation and David Oros are the most recent …See details»
eNeura Therapeutics - Contacts, Employees, Board Members
Organization. eNeura Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Number of …See details»
eNeura CEO and Key Executive Team | Craft.co
ENeura's CEO & Board Director is David K. Rosen. Other executives include Thomas C. Hoster, CFO; Terese M. Baker, VP, Marketing and 1 others. See the full leadership team at Craft.See details»
M.Eng. Projects: eNeura Migraine Device - Cornell University
Of the eNeura-M.Eng. collaboration, David Fischell said, “My dad (Robert) and I were extremely impressed by the creativity and engineering of the student team." With the device now …See details»
eNeura, Inc. Receives FDA Clearance for Acute Treatment and …
Feb 27, 2019 eNeura, Inc. is a privately held medical technology company that is pioneering the use of portable, non-invasive, non-drug treatment and prevention of migraine. sTMS is a …See details»
Your Information. Your Rights. Our Responsibilities. - Eneura
Organization U We can use and share your health information to run our practice, improve your care, and contact you when necessary. ... Email: [email protected] Leave a secure …See details»
About Migraine | sTMS mini™ Migraine Therapy from eNeura
About Migraine. Migraine impacts 1 in 7 people worldwide. It is most common between the ages of 15 and 55 and is 3 times more common in women. Nearly 1 in 4 women are likely to have …See details»
eNeura receives 510(k) for second-generation migraine treatment …
May 23, 2014 Following the FDA's de novo approval of eNeura's device for the treatment of pain from migraine headaches with aura--a decision FierceMedicalDevices designated as one of …See details»
Eneura
The eNeura Clinical Specialist will walk you through your first treatment, step-by-step. You’ll find it’s remarkably simple. We are here to help. [email protected]. 1-833-499-9300, …See details»
eNeura Achieves Record-Breaking Sales and Announces Notice of …
Apr 26, 2024 As eNeura continues to advance its mission of enhancing the lives of individuals afflicted by chronic migraines, the company remains steadfast in its commitment to innovation, …See details»
eNeura, Inc. Receives FDA Clearance for Acute Treatment and …
Feb 27, 2019 eNeura, Inc. is a privately held medical technology company that is pioneering the use of portable, non-invasive, non-drug treatment and prevention of migraine. sTMS is a …See details»